ZBTB16 and acute promyelocytic leukemia: ZBTB16 was first identified in acute promyelocytic leukemia as a transcriptional suppressor of the t(11;17) translocation.6 Many studies have shown that during different biological processes, such as proliferation,7 differentiation8 and apoptosis9, ZBTB16 exerts dual effects on transcription.